Markets › Stocks › SANDUPHQ
SA

Sandu Pharmaceuticals Ltd.

NSE: SANDUPHQBSE: 524703Healthcare
Download Research Report7-page PDF
₹43.80
▲ +3.06%
NSE · auto-updates while market open
Mkt Cap
₹41 Cr
P / E
23.2
P / B
0.9
ROE
4.1%
52W High
₹49.00
52W Low
₹37.00
Key Metrics
Market Cap
₹41 Cr
P / E
23.20
P / B
0.94
EV / EBITDA
11.54
ROCE
6.4%
ROE
4.1%
Debt / Equity
0.01
Book Value
₹45.21
EPS
₹1.83
Div Yield
0.0%
Face Value
-
Promoter Holding
37.8%
Revenue · ₹ Cr
66
FY22
65
FY23
67
FY24
67
FY25
70
FY26
Net Profit · ₹ Cr
2
FY22
2
FY23
1
FY24
2
FY25
2
FY26
EPS · ₹ per share
₹2.0
FY22
₹1.6
FY23
₹1.5
FY24
₹1.6
FY25
₹1.8
FY26
Q1 2025 snapshot
Sales
₹14 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.34
Scorecard · 7 axes
Quality
Avg
45/100
Valuation
Good
23.2×
Growth
Weak
+2.2%
Profitability
Weak
5.3%
Performance
-
Entry Point
Avg
89%
Red Flags
Strong
0 flags
Shareholding Pattern
37.8%Promoter
Promoter37.8%
DII0.0%
Public62.2%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue18.414.1416.7217.6718.7717.22
Net Profit0.5560.3270.2230.5240.9750.043
NPM %3.0%2.3%1.3%3.0%5.2%0.3%
AlertPre-trade